All News

2057 articles, sorted by publication time.

Cancer Medicine · global

Personalized mRNA Cancer Vaccine Clears Phase 3 Hurdle: New Evidence in Postsurgical Melanoma Treatment

Moving from long-term signals in a small trial to Phase 3 validation in 1,137 patients, intismeran combined with immunotherapy met recurrence-free and distant metastasis-free survival endpoints. This is an important advance, but the preliminary results announced in August have yet to establish the magnitude of benefit or whether the treatment extends life.